Open access · OA
via OpenAlex
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease
Hiroshige Kojima, Osamu Yokosuka, Fumio Imazeki, Hiromitsu Saisho, Masao Omata
Gastroenterology · 1997 · ▲ 161 citations
Abstract
This 1997 Gastroenterology study examines telomerase activity and telomere(definition) length within the context of hepatocellular carcinoma and chronic liver disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1053/gast.1997.v112.pm9024303
- Canonical
- link ↗
- Fetched
- 2026-06-22 MST
Cite this
APA
Kojima, H., Yokosuka, O., Imazeki, F., Saisho, H., & Omata, M. (1997). Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. <em>Gastroenterology</em>. https://doi.org/10.1053/gast.1997.v112.pm9024303
Vancouver
Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology. 1997. doi:10.1053/gast.1997.v112.pm9024303.
BibTeX
@article{hiroshige1997Telome,
title = {Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease},
author = {Hiroshige Kojima and Osamu Yokosuka and Fumio Imazeki and Hiromitsu Saisho and Masao Omata},
journal = {Gastroenterology},
year = {1997},
doi = {10.1053/gast.1997.v112.pm9024303},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Gastroenterology 2007
Open access · OA
Telomerase Deletion Limits Progression of p53-Mutant Hepatocellular Carcinoma With Short Telomeres in Chronic Liver Disease
Biomarkers in disease 2022
Citation only
Telomere Length
Biomarkers in disease 2022
Citation only
Telomere Length
Nature Reviews Disease Primers 2021
Open access · OA
Hepatocellular carcinoma
Clinica Chimica Acta 2020
Citation only
Bone, inflammation and chronic kidney disease
Immunity 1998
Open access · OA